Why the study?
Does the pharmacodynamic effect of enoxaparin correlate with its pharmacokinetics in patients receiving dialysis therapies compared to healthy volunteers?
Does the pharmacodynamic effect of enoxaparin correlate with its pharmacokinetics in patients receiving dialysis therapies compared to healthy volunteers?
In dialysis patients, enoxaparin causes greater prolongation of thrombin generation time despite similar antifactor Xa exposure compared to healthy volunteers, suggesting standard monitoring may not accurately reflect its pharmacodynamic effect.
Answers are grounded in this paper and cite their sources.
Anti-Xa monitoring may underestimate enoxaparin's PD effect in dialysis; hypothesis-generating for TGT-guided strategies.
The pharmacokinetics and pharmacodynamics of enoxaparin were studied in healthy volunteers and hemodialysis and peritoneal dialysis subjects. Antifactor Xa activity estimated the pharmacokinetics, whereas thrombin generation time (TGT) estimated the pharmacodynamics. Enoxaparin 1 mg/kg was given subcutaneously to all subjects. Antifactor Xa Amax and AUC(0-12) were similar between groups, but the TGTmax was significantly greater in the dialysis groups (P = .001). The thrombin generation time remained significantly more prolonged throughout the 12-hour study period, and there was a trend toward greater TGT AUEC(0-12) for both dialysis groups (P = .07). Patients receiving hemodialysis had greater sensitivity to enoxaparin compared to the other groups. These results suggest that in dialysis patients, there may be accumulation of active heparin metabolites that are undetected by the antifactor Xa assay. Therefore, these subjects exhibit greater thrombin generation time prolongation despite similar antifactor Xa exposure. Further large-scale studies are needed to corroborate the results of this exploratory pilot study.
No takes yet. Share an insight, caveat, or question.
Brophy et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: